THERESA LENSING: Open Payments
NPI 1174395917 · JAMESTOWN, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $454 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| PFIZER INC. | 2 | $29 |
| ABBVIE INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| MIMEDX Group, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: TRINTELLIX, Jornay PM, VOQUEZNA, NURTEC ODT, OTEZLA, QULIPTA, Ozempic, EVENITY.
Industry payments across ND — which companies pay providers there.
